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INTRODUCTION 
 
The link between aging and neoplastic disease is widely 
acknowledged. In addition, it is increasingly apparent 
that some of the most relevant risk factors for cancer in 
humans are also associated with signs of accelerated 
aging in their target organ. Examples include smoking 
for the respiratory mucosa, chronic hepatitis for the 
liver, UV light for the skin, chronic (atrophic) gastritis 
for the stomach, among others [1-7]. This underscores 
the argument that the pathophysiology of aging is 
strictly intertwined with that of carcinogenesis, to the 
point that the emergence of the aged phenotype stands 
as  a  major  biological  driving force towards neoplastic 
 
development. Nevertheless, this association is still 
awaiting a fully satisfactory mechanistic explanation. 
 
In approaching this issue, transplantation studies 
conducted by our research group revealed that the 
microenvironment of the aged rat liver is permissive for 
the clonal growth of both normal and pre-neoplastic 
hepatocytes, while the same cells, either normal or pre-
neoplastic, do not expand when seeded in the liver of 
young recipients [8, 9]. Furthermore, pre-neoplastic 
hepatocytes were able to progress to form large tumors in 
aged hosts, while no lesions were detected in animals 
transplanted at young age even after several months of 
follow-up [9]. Based on this evidence, we have proposed 
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ABSTRACT 
 
Aging increases the risk of cancer partly through alterations in the tissue microenvironment. Time-restricted 
feeding (TRF) is being proposed as an effective strategy to delay biological aging. In the present studies, we 
assessed the effect of long-term exposure to TRF on the emergence of the age-associated, neoplastic-prone 
tissue landscape. Animals were exposed to either ad libitum feeding (ALF) or TRF for 18 months and then 
transplanted with hepatocytes isolated from pre-neoplastic nodules. Both groups were continued ALF and the 
growth of transplanted cells was evaluated 3 months later. A significant decrease in frequency of larger size 
clusters of pre-neoplastic hepatocytes was seen in TRF-exposed group compared to controls. Furthermore, TRF 
modified several parameters related to both liver and systemic aging towards the persistence of a younger 
phenotype, including a decrease in liver cell senescence, diminished fat accumulation and up-regulation of 
SIRT1 in the liver, down-regulation of plasma IGF-1, decreased levels of plasma lipoproteins and up-regulation 
of hippocampal brain-derived growth factor (BDNF).These results indicate that TRF was able to delay the onset 
of the neoplastic-prone tissue landscape typical of aging. To our knowledge, this is the first investigation to 
describe a direct beneficial effect of TRF on early phases of carcinogenesis. 
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that a relevant contribution of aging towards increasing 
the risk of cancer is related to the emergence of an age-
associated, clonogenic and neoplastic-prone tissue land-
scape [10], the declining cellular fitness of the aged tissue 
being a selective driver for clonal growth, as it has been 
suggested for the hematopoietic system  [11, 12]. 
 
While the aging process per se is largely unavoidable, 
the rate of aging is amenable to modulation. Decades of 
studies have indicated that dietary control is among the 
most effective strategies to delay aging and age-related 
diseases, including cancer [13].  Most consistent results 
have been obtained with caloric restriction, i.e. a 
reduction of total daily calories without causing 
malnutrition. Both lifespan and healthspan extensions 
were reported in virtually all species that were fed a 
caloric-restricted diet, although some controversies do 
exist regarding the interpretation of data obtained in 
non-human primates [14]. However, practical difficult-
ties and theoretical concerns limit the applicability of 
caloric restriction regimens to humans [15]. An 
alternative approach that is being actively explored for 
its potential benefits is time-restricted feeding (TRF) 
[16]. In this dietary protocol food consumption is not 
randomly distributed across the 24 hours, but it is 
limited to a daily interval of 8 to 12 hrs, while the total 
amount of ingested calories is comparable to that of ad 
libitum fed (ALF) controls. The main rationale of TRF 
regimen is that the time of food intake should be aligned 
with internal circadian rhythms, in order to synchronize 
with tissues metabolic needs [17]. An increasing 
number of studies have indeed indicated that TRF is 
able to reproduce at least some of the effects associated 
with caloric restriction, particularly on metabolism [18]. 
Thus, TRF was shown to prevent excess increase in 
body weight both in Drosophila melanogaster [19] and 
in mice fed either regular or high fat diets [20].  
Moreover, TRF could also reverse pre-existing diet-
induced obesity, both after long and short-term 
exposure [16, 21], as well as diet-induced liver 
steatosis and the accompanying increase in serum 
markers of liver disease  [22], while plasma levels of 
triglycerides and low density lipoproteins were 
decreased [16, 22]. A beneficial effect of TRF on the 
emergence of insulin resistance has also been reported 
in young and middle-aged mice [16, 20]. Most 
recently, a TRF regimen was also shown to increase 
lifespan in mice [23]. 
 
Limited evidence is available so far on the possible 
impact of TRF on neoplastic disease. A retrospective 
epidemiological study in humans reported a positive 
correlation between protection from breast cancer risk 
and duration of overnight fasting period [24]. In a more 
recent report, exposure to TRF for 8 weeks was found 
to mitigate high-fat diet-enhanced mammary tumori-
genesis in the mouse mammary tumor virus-polyoma 
middle tumor-antigen (MMTV-PyMT) model [25]. 
Based on these premises, the present investigation 
analyzes the effect of long term TRF on the emergence 
of the age-associated, neoplastic-prone tissue micro-
environment in rat liver. Furthermore, the possible 
effect of TRF on liver specific and systemic, age-related 
phenotypic alterations is also addressed. 
 
RESULTS 
 
Food consumption and growth curves 
 
Animals were assigned to TRF or ALF group at 8 
weeks of age and they were maintained on their 
respective dietary regimens for 18 months (Figure 1A). 
When computed over the entire period, average daily 
food intake was 19.1±0.7 and 17.2±0.5 for ALF and 
TRF groups, respectively. However, during the last 3 
months of the study, when all groups were fed ad 
libitum, food consumption in TRF group slightly 
exceeded that of controls (21.2±0.6 vs. 20.4±0.9 
g/rat/day, respectively) (Figure 1B). 
 
Interestingly, when food intake was normalized per 
body weight, no significant differences were observed 
throughout the 18 months of exposure to either dietary 
regimens (Figure 1C). 
 
Body weight was monitored weekly for the entire 
duration of the experiment (Figure 1D). Animals given 
TRF regimen showed a slightly lower weight gain 
compared to controls fed ad libitum; the difference 
became statistically significant after about 5 months and 
persisted thereafter, until 18 months, when it was 89% 
of controls. However, during the last 3 months, when 
TRF group was fed ad libitum, body weight increased 
and reached values similar to controls. Relative liver 
weights at the end of the experiment were not 
significantly different in the two groups (Figure 1E). 
 
The growth of transplanted pre-neoplastic cells  
 
In order to evaluate whether TRF had any effect on the 
onset of the neoplastic-prone tissue microenvironment 
typical of the aged liver [10], animals were exposed to 
this dietary regimen for 18 months. They were then 
switched to ALF and they were transplanted with 
hepatocytes isolated from chemically-induced hepatic 
nodules (See Methods for details). Three months later 
they were killed and the growth of pre-neoplastic 
hepatocytes was assessed. Livers were excised and 
analyzed both macroscopically and histologically. 
 
A few visible hepatocyte nodules were discerned on 
gross examination; their incidence is reported in Table 
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1. While numbers were insufficient for statistical 
analysis, a trend towards a decrease was seen in TRF 
group. 
 
Histochemical analysis was performed in order to detect 
DPPIV-expressing, transplanted pre-neoplastic hepato-
cyte clusters (Figure 2A and B). Ten sections per animal 
were considered. No significant differences were 
observed in the total number of clusters/unit area 
between the two groups, as expected. Percent cluster 
size distribution in each group is reported in Figure 2C. 
Singlets, i.e. single DPPIV-positive hepatocytes, added 
up to 28.2±12.4 and 37.1±9% of all clusters in ALF and 
TRF groups, respectively. Small clusters, i.e. comprising 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 to 5 cells per cross section, were 21.1±13.0 and 
26.8±18.2% of the total in ALF and TRF groups, 
respectively; finally, larger clusters, i.e. comprising a 
minimum of 6 and up to 20 cells, were 9.9±7.6 and 
3.1±3.6% in ALF and TRF groups, respectively. Thus, 
larger clusters were about 3-times as frequent in ALF 
compared to TRF group and these differences were 
statistically significant (Figure 2C). 
 
Immuno-histochemical detection of Ki67 revealed very 
low levels of labelling (<0.1%) in both trans-planted 
hepatocyte clusters and surrounding host liver, with no 
intergroup differences between ALF and TRF treated 
animals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation of experimental protocol (A). Food intake (B and C), growth curves (D) and relative liver 
weights (E) in animals from ALF or TRF groups. Significant differences between ALF and CRF groups are indicated where appropriate 
(*p <0.05, **p <0.01, ***p <0.001). 
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Histological analysis of liver samples with standard 
H&E staining revealed the presence of prominent 
cholangio-fibrosis and bile ductular proliferation, which 
have long been described in the aging liver [26]. They 
were a more frequent finding in rats fed ad libitum 
throughout the experiment (Figure 2D and E). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time-restricted feeding and the aging liver 
 
We next investigated whether TRF regimen had any 
effect on the appearance of phenotypic alterations that 
have been associated with the aging process in the 
liver.  
 
Figure 2. The growth of transplanted pre-neoplastic hepatocytes in the liver of rats exposed to ALF or TRF regimens 
for 18 months. Following transplantations, animals from both groups were continued on ALF for 3 months (see Methods for 
details). Larger class clusters of DPP-IV expressing, pre-neoplastic hepatocytes (A, B and C) were significantly more frequent in ALF 
compared to TRF group (*p <0.05 and **p <0.01). (D and E) H&E staining of livers from ALF or TRF groups, respectively. Note the 
presence of cholangio-fibrosis, more prominent in ALF group. Magnification:  A and B, 200x; D and E, 100x. 
 
Table 1. Liver lesions in rats transplanted with pre-neoplastic hepatocytes. 
Nutritional behaviour  Total animals  with lesion 
Total lesion  
per group Size range 
Ad Libitum Feeding 4/4 8 2 mm 
Time-Restricted Feeding 3/6 3 1.5-4 mm 
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Cell senescence 
Cell senescence entails a persistent/irreversible arrest of 
the cell cycle associated with distinct phenotypic 
changes [27]. Senescent cells increase with age in many 
tissues, including liver, although their precise 
mechanistic role in the overall aging process is yet to be 
defined, if any [28]. The enzyme senescence-associated 
β-galactosidase (SA-β-Gal), located in the lysosomal 
compartment, is the most widely used biomarker for 
senescent cells [29]. We performed histochemical 
staining of liver sections obtained from ALF or TRF 
groups, treated as described in the previous paragraph 
(18 months on ALF or TRF regimens, followed by 3 
months of ad libitum diet). Three sections from each 
lobe were processed and expression of SA-β-Gal was 
estimated using an image analyzer (Figure 3A and B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As reported in Figure 3C, a significant decrease in 
percent SA-β-Gal-positive areas/total was found in TRF 
group compared to controls.  
 
Nutrient sensing pathway 
Alterations in nutrient sensing pathways are considered 
as one of the “hallmarks” of aging, and several lines of 
evidence suggest that such altered metabolic regulation 
does in fact represent a candidate driver of the aging 
process [30]. An important role in this context is played 
by sirtuins, a family of NAD-dependent protein de-
acetylases involved in diverse mechanisms associated 
with the emergence of the aging phenotype. Over-
expression of SIRT1, a member of the sirtuin family, 
has been associated with increased longevity and/or 
healthy ageing, possibly via interaction with major  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The effect of TRF on markers of liver aging in rats exposed to ALF or TRF for 18 months and continued 
on ALF for additional 3 months. (A, B and C) SA-β-gal staining. Percent area positive for SA-β-gal staining was decreased in 
TRF compared to ALF group (**p- value <0.01). (D and E) Western blot analysis of SIRT1 expression.  A significant up-regulation 
was seen in TRF group (**p-value <0.01). (F, G and H) Immunofluorescence analysis of intracellular lipid accumulation (red) in 
the liver. Nuclei were stained with Hoechst (blue). A decrease in lipid droplets was evident in TRF group (*p- value <0.05).  
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nutrient sensing pathways of longevity, such as mTOR, 
FOXO and insulin-IGF-1 signaling network [31]. 
Furthermore, the beneficial effects of caloric restriction 
on metabolism have been attributed, at least in part, to 
up-regulation of Sirt1 [32, 33]. We therefore invest-
tigated whether long-term exposure to TRF was able to 
modify the expression of SIRT1 in the liver. As shown 
in Figure 3D and E, a 3-fold increase in SIRT1 protein 
levels was indeed found in TRF group compared to 
controls. 
 
Fat accumulation 
Aging is an important risk factor for development of 
hepatic steatosis [34]. In order to further explore the 
effect of long term TRF on the emergence of age-
associated phenotypes in the liver, the extent of hepatic 
lipid accumulation was determined in animals exposed 
to this dietary regimen for 18 months, followed by 3 
months of ALF. Cryostat sections obtained from ALF 
or TRF-treated rats were stained with HCS LipidTOX™ 
Red phospholipidosis detection reagent (Figure 3F and 
G). Quantitation of lipid droplets revealed a signifi-
cantly decreased accumulation in the livers of rats 
exposed to TRF (Figure 3H).  
 
Time-restricted feeding and systemic aging 
 
We then explored the effect of long-term exposure to 
TRF on the emergence of age-associated biochemical 
and metabolic alterations at systemic level.  
 
Plasma IGF-1 
Circulating levels of insulin-like growth factor 1 (IGF-
1) have been inversely correlated with lifespan in 
several strains of mice, supporting the hypothesis that 
its pathway plays a key role in regulating longevity 
[35]. Accordingly, drugs that prevent IGF-1 release or 
its binding to the membrane receptor are being proposed 
as a means to extend lifespan [36]. Using ELISA 
method, we determined plasma levels of IGF-1 in rats 
treated with ALF or TRF dietary regimen for 18 
months, and then continued on ALF for 3 months. As 
reported in Figure 4A, significantly lower levels of IGF-
1 were detected in TRF group compared to controls.  
 
Brain derived neurotrophic factor (BDNF) 
Aging also entails a progressive decline of cognitive 
functions. Brain-derived neurotrophic factor (BDNF) 
plays an important role in memory formation, neuron 
plasticity and cell proliferation. Considering the 
decreased levels of BDNF in the ageing hippocampus, 
several studies have suggested a mechanistic role for 
this neurotrophic factor in age-related hippocampal 
dysfunction, memory weakening and increased risk of 
neurodegenerative diseases [37]. Most recently, BDNF 
has also been linked to a host of beneficial effects at 
systemic level, including decreased adiposity, improved 
glucose tolerance and reduced steatosis [38]. Thus, to 
gain further insights into the effect TRF on the aging 
phenotype, levels of BDNF were measured in plasma 
and in the hippocampus of rats under the specific 
experimental conditions of our studies. Plasma and 
hippocampal cell lysate were analyzed for BDNF 
peptide. Higher levels of BDNF were observed in both 
the hippocampus and in plasma of animals exposed to 
TRF, albeit differences were statistically significant 
only in the hippocampus (Figure 4B and C). 
 
Blood lipid profile 
Changes in plasma lipid profile are a frequent finding 
during aging (as also observed in these studies, Figure 
4D) and are implicated in the pathogenesis of most 
common human chronic diseases, such as cardio-
vascular disease [39]. Recent data suggest that TRF 
might represent a reasonable and viable strategy to 
counter the age-associated rise in the incidence of 
dyslipidemia [22, 40]. We tested this possibility under 
our experimental conditions: plasma lipids, including 
triglycerides (TG), low density lipoproteins (LDL) and 
high density lipoprotein (HDL), were measured in rats 
exposed to ALF or TRF for 18 months, followed by 
ALF for an additional 3 months. As reported in Figure 
4E, TRF treatment was associated with significantly 
decreased levels of all lipid parameters, in agreement 
with results of previous studies [16]. Since con-
centrations of plasma lipids increased with age in 
control ALF group (Figure 4D), the lowering effect of 
TRF on these parameters is more correctly interpreted 
as a delay in their age-associated increase. 
 
DISCUSSION 
 
Taken together, the results of the present studies 
indicate that long-term exposure to TRF retards the 
onset of the clonogenic and neoplastic-prone hepatic 
tissue microenvironment associated with aging. Further-
more, several age-related alterations were countered by 
TRF both in the liver and at systemic level.  
 
Using an experimental protocol based on syngeneic cell 
transplantation, hepatocytes isolated from chemically-
induced liver nodules were injected in recipient rats 
following 18- month exposure to TRF regimen. 
Animals were then continued on ALF diet in order to 
avoid a direct effect of TRF on the rate of growth of 
transplanted cells. Clusters size was evaluated 3 months 
later. A significant decrease in the frequency of larger 
size clusters of pre-neoplastic hepatocytes was seen in 
TRF-exposed group compared to controls given ALF 
throughout the experiment. This indicates that TRF 
regimen was able to delay the emergence of the 
clonogenic and neoplastic-prone tissue soil typical of 
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aging. It is worth noting that the present results parallel 
very closely those reported by our research group 
following exposure to caloric restriction. It was shown 
that the retarding effect a calorie-restricted diet on 
neoplastic development was attributable, to a large 
extent, to a decreased clonogenic potential of the liver 
microenvironment exposed to caloric restriction [41].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The clonogenic drive of aged, phenotypically normal 
tissues has been highlighted in recent years by several 
studies indicating that clonal expansions are a frequent 
finding in old healthy individuals (including humans), 
to the point that they should come to be considered as a 
normal, and in fact a universal marker of advancing age 
[42, 43]. Since such clonal expansions include (but are  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The effect of TRF on markers of systemic aging in rats exposed to ALF or TRF for 18 months and 
continued on ALF for additional 3 months. (A) Plasma levels of IGF-1 were decreased in TRF group (p-value <0.05). (B and C) 
BDNF levels in the hippocampus and plasma; differences were statistically significant in the hippocampus (*p-value <0.05). (D) 
Plasma triglycerides, LDL and HDL levels in rats after 1 or 2 years on ALF regimen. A significant increase in all parameters was seen 
at 2 years (**p <0.01; ***p <0.001). (E) Plasma lipids profile in rats exposed to ALF or TRF for 18 months and continued on ALF for 
additional 3 months. Rats receiving TRF had lower levels of triglycerides, LDL and HDL (*p-value <0.05; **p-value <0.01). 
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not limited to) cell populations with pre-neoplastic 
potential (e.g. carrying mutations associated with cancer 
[42, 43]), it follows that the proneness to foster clonal 
expansions of the aged tissue microenvironment 
constitutes a risk factor for the emergence of neoplastic 
disease  [44]. 
 
To our knowledge, this is the first investigation to 
describe a direct beneficial effect of long term TRF on 
early phases of carcinogenesis. It was recently reported 
that a time-caloric restricted diet could inhibit 
progression from cirrhosis to hepatocellular carcinoma 
induced by chronic administration of diethylnitrosamine 
[45]. However, feeding time in this study was reduced 
to 2 hours, resulting in a sizeable (~30%) decrease in 
daily caloric intake. Interestingly, epidemiological 
studies in women have suggested that prolonged nightly 
fasting may decrease the risk of breast cancer [46] and 
breast cancer recurrence [24]. Most recently, exposure 
to TRF for 8 weeks was found to mitigate high-fat diet-
enhanced mammary tumorigenesis in the MMTV-
PyMT mouse model [25].  
 
Evidence was also obtained in our studies that TRF is 
able to delay the onset of age-associated phenotypic 
alterations, extending previous findings published in the 
literature [18, 20]. Parameters related to both liver and 
systemic ageing were in fact found to be modulated by 
TRF towards the persistence of a younger phenotype, 
including a decrease in liver cell senescence, lower 
incidence of cholangiofibrosis, diminished fat accumu-
lation and up-regulation of SIRT1 in the liver, down-
regulation of plasma IGF-1, decreased levels of plasma 
lipoproteins and up-regulation of hippocampal BDNF. 
Of note, the beneficial effect of TRF on the above 
parameters was still detectable after 3 months of ALF 
diet, suggesting that it reflects persistent biological 
adaptations as opposed to transient metabolic alterations.  
 
The finding that TRF is effective in delaying aging 
phenotypes has two major implications. Firstly, from a 
practical point of view TRF stands as a dietary manipu-
lation that is more amenable to implementation in 
humans compared to caloric restriction [16]. Moreover, 
caloric restriction can carry important side effects such 
as infertility, depression, osteoporosis, slower wound 
healing and others [15].  In fact it is well known that 
dietary restriction in adults may decrease reproductive 
potential in both sexes, possibly due to re-allocation of 
resources from reproduction to survival [47, 48], while 
in young and growing animals it is associated with a 
reduced skeletal bone acquisition, resulting from 
suppression of bone formation and activation of bone 
resorption [49]. Since TRF does not imply a (major) 
reduction in total calories, the above contraindications 
do not apply.  
Secondly, as a follow up to the latter consideration, if 
several effects of CRF can be reproduced by TRF with 
no decrease in caloric intake, the implication is that the 
beneficial effects of the former are mediated, at least in 
a relevant part, by biochemical/molecular mechanisms 
set in motion by the latter [23]. Thus, there is a need for 
new mechanistic hypotheses to be pursued as to the 
aging-retarding effects of TRF and CRF. Placing 
emphasis on the time component of feeding behavior, as 
opposed to the amount of food per se, brings attention 
to the interplay of the pattern of food ingestion with 
peripheral circadian clocks and to their relation to the 
rate of aging [50, 51]. This is in line with the increasing 
awareness in the literature of the concept of “chrono-
nutrition”, i.e. the notion that food consumption should 
be aligned and resonate with body’s daily rhythms in 
order to prolong healthspan [50]. The underlying 
implication is that a better understanding and fine-
tuning of this reciprocal interaction has the potential to 
widen our opportunities for effective interventions 
towards delaying ageing. 
 
As a note of caution, we are aware of the fact that, in 
our studies, animals exposed to TRF had also a 
significant, albeit limited component of CRF, since food 
consumption was about 10% less, on average, in TRF 
compared to ALF group. While such a small difference 
in food intake would appear unlikely to be effective in 
retarding aging unless it is coupled with a TRF regimen, 
such a possibility cannot be ruled out at present and 
deserves further investigations.  
 
In summary, the present studies provide the first direct 
evidence that a TRF regimen is able to delay the 
emergence of the neoplastic prone/clonogenic tissue 
landscape associated with ageing. This specific outcome 
is part of a more generalized beneficial effect of TRF on 
several biological, biochemical and metabolic para-
meters related to the aging phenotype.  
 
MATERIALS AND METHODS 
 
Animals and diet 
 
Experiments were performed using Fischer 344 male 
rats. Animals were maintained on an alternating 12 
hours light/dark cycle (light phase from 7AM to 7PM), 
in a temperature and humidity-controlled environment, 
with water available ad libitum and housed two for each 
cage. They were fed a standard rodent laboratory chow 
diet (Mucedola, Settimo Milanese, Italy, #4RF21). 
Animal studies were reviewed and approved by the 
Institutional Animal Care and Use Committee of the 
University of Cagliari (Italy) and were performed in 
accordance with the relevant guidelines and regulations. 
Eight weeks old male rats were randomly divided into 2 
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groups of 10 animals each: ad libitum feeding (ALF) 
group, which had free access to food throughout the 
experiment; time-restricted feeding group (TRF), which 
had access to food for 8 hours during the dark phase, 
starting at 11PM until 7AM. Body weight was 
measured weekly whereas food consumption was 
measured daily for TRF and weekly for ALF. Such 
feeding regimens were maintained for 18 months. All 
animals were then continued on ALF diet for an 
additional period of 3 months. One week after the latter 
dietary change, both groups were transplanted with pre-
neoplastic hepato-cytes isolated from syngeneic donor 
(see below). Three months after transplantation, 
animals were killed and blood, liver and brain tissue 
were collected for analysis.   
 
Generation of hepatic nodules and isolation of pre-
neoplastic hepatocytes 
 
To follow the fate of donor pre-neoplastic hepatocytes 
into the recipient liver, the dipeptidyl peptidase type IV 
(DPPIV)-deficient rat model was used [9]. Hepatocyte 
nodules were induced in DPPIV expressing animals 
according to a modified version of the Solt and Faber 
protocol. Nine to ten months after treatment, livers were 
perfused according to a standard 2-step collagenase 
perfusion technique. Cell viability, determined by 
trypan blue dye exclusion, was 90-95%. Pre-neoplastic 
cells (6x105 cells/animal) were transplanted into the 
liver of DPPIV-deficient syngeneic recipients, via a 
mesenteric vein. All procedures were performed as 
previously reported [9]. 
 
Histological analyses 
 
Standard histological analysis was performed on 
formalin-fixed paraffin-embedded tissue sections after 
H&E staining. To follow the fate of transplanted cells, 
histochemical staining for the detection of DPPIV was 
performed on 5 µm-thick frozen sections as previously 
described [9]. Staining for SA-β-gal was performed on 
7 µm-thick cryostat sections according to published 
procedures [52]. Liver tissue lipid accumulation was 
assessed on 5 µm-thick frozen sections using HCS 
LipidTOX™ Red phospholipidosis detection reagent 
(Thermo Fisher Scientific, Waltham, MA, USA, 
#H34351). Immuno-histochemical staining for Ki67 was 
carried out on 5-µm thick frozen sections fixed in 0.1% 
acetic acid/ethanol, washed in PBS and blocked with goat 
serum. Primary antibody (Abcam, Cambridge, MA, 
#ab16667) was applied overnight at 4 °C; detection of 
specific signal was accomplished using an alkaline 
phosphatase (AP)-conjugated secondary antibody system 
(Vectastain ABC and substrate kits; Vector Labs, 
Burlingame, CA, #AK-5001 and #SK-5300). 
Western blot analysis 
 
Western blot analysis was performed on nuclear 
proteins extracted from liver samples using a 
commercially available kit (NE-PER™, Thermo Fisher 
Scientific, #78835). Protein concentration was 
measured using the Bicinchoninic Acid Kit (Sigma-
Aldrich, Saint Louis, MO, USA, #BCA1). Samples 
were prepared in Laemmli buffer, boiled at 95°C for 5’, 
loaded into SDS-PAGE precast Criterion TGX Stain-
Free gels (Bio-Rad, Hercules, CA, USA) and run under 
denaturing conditions. Proteins were transferred onto 
PVDF membranes, blocked with 5% non-fat milk for 
45’ at room temperature, followed by incubation with 
primary antibodies overnight at 4°C (SIRT1: Santa Cruz 
Biotechnology, Dallas, TX, USA, #SC-15404 1:1000; 
β-actin: Abcam, Cambridge, UK, #ab8227 1:10000). 
Membranes were then washed and incubated for 2 h at 
room temperature with secondary antibody conjugated 
with HRP (anti-rabbit IgG: Abcam, #ab205722 
1:10000). Protein bands were detected using a chemi-
luminescent substrate (Bio-Rad, #1705061) and imaged 
onto Kodak film. 
 
Blood and brain tissue analyses  
 
Concentration of plasma lipids was measured using 
commercially available reagents, according to 
manufacturer’s instructions (HDL and LDL, Sigma-
Aldrich, #MAK045; Triglycerides, Sigma-Aldrich, 
#MAK266).    
 
Sandwich ELISA was performed on plasma samples for 
the quantitative analysis of target proteins using 
commercially available kits, according to manufac-
turer’s instructions. Adiponectin: R&D Systems, 
Minneapolis, MN, USA, #RRP300; Leptin: BioVendor, 
Brno, Czech Republic, #RD291001200R; IGF-1: 
Medignost, Reutlingen, Germany, #E25; BDNF Merck, 
Darmstadt, Germany.  
 
Sandwich ELISA was also performed on total protein 
extracts from the hippocampus, for the analysis of 
BDNF, using kit #RAB1138 (Sigma-Aldrich). 
 
Final absorbance was read on a microplate reader 
(Infinite F200 pro, Tecan, Männedorf, Switzerland).  
 
Image analysis, graphical representation of results 
and statistical analysis 
 
Acquired microscopic images were processed for 
quantitative analysis using Image-Pro Premier software 
(Media Cybernetics, Rockville, MD, USA). Western 
blots were densitometrically quantified with ImageJ 
software (NIH, USA). Graphical representation of 
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quantitative results and statistical analysis were 
performed using Prism 5 software (GraphPad Software, 
La Jolla, CA, USA). 
 
Data availability 
 
The data that support the findings of this study are 
available from the authors upon reasonable request and 
with permission of the Institutional Review of the 
University of Cagliari. 
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